@article{43ebdb1cd9464dfd911057c4097c8045,
title = "Adenovirus Armed With TNFa and IL2 Added to aPD-1 Regimen Mediates Antitumor Efficacy in Tumors Refractory to aPD-1",
keywords = "cancer immunotherapy, oncolytic virus, adenovirus, checkpoint inhibitor resistance, tumor microenvironment, IMMUNE CHECKPOINT INHIBITORS, NECROSIS-FACTOR-ALPHA, T-CELL THERAPY, ACQUIRED-RESISTANCE, ONCOLYTIC VIRUSES, PD-1 BLOCKADE, COMBINATION, IMPROVES, LANDSCAPE, 3111 Biomedicine",
author = "Victor Cervera-Carrascon and Quixabeira, {Dafne C. A.} and Santos, {Joao M.} and Riikka Havunen and Ioanna Milenova and Jan Verhoeff and Camilla Heinio and Sadia Zafar and Garcia-Vallejo, {Juan J.} and {van Beusechem}, {Victor W.} and {de Gruijl}, {Tanja D.} and Aino Kalervo and Suvi Sorsa and Anna Kanerva and Akseli Hemminki",
year = "2021",
month = jul,
day = "23",
doi = "10.3389/fimmu.2021.706517",
language = "English",
volume = "12",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media SA",
}